Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Kedudukan dalam Saham #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Harga Saham
$1.51
Disegerakkan terakhir: 2024-08-26
Modal Pasaran
$1.12M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Agile Therapeutics, Inc. (AGRX)

Kategori

Sejarah harga saham bagi Agile Therapeutics, Inc. (AGRX)
Harga penutupan tertinggi: $1.47 pada 2024-08-01

Harga penutupan terendah: $11.47 pada 2014-05-01
Sejarah harga saham Agile Therapeutics, Inc. dari 2014 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2024 -30.09%
2023 -78.45%
2022 -15.65%
2021 -80.13%
2020 30.68%
2019 217.54%
2018 -77.75%
2017 377.61%
2016 -20.90%
2015 33.79%
2014 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$171.67 -
DE
$161.67 25.08%
DE
$36.61 23.93%
JP
$225.00 38.71%
CH
$21.30 13.79%
IN